Parisa Malekzadeh MD
Colon & Rectal Surgery, Melanoma, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Physician
320 W 6th StDept Of SurgeryCorona, CA 92882
Overview of Dr. Malekzadeh
Dr. Parisa Malekzadeh is a general surgeon in Corona, CA and is affiliated with multiple hospitals in the area, including City of Hope Comprehensive Cancer Center and Sentara Leigh Hospital. She received her medical degree from University of Arizona College of Medicine-Tucson and has been in practice 10 years. She is one of 37 doctors at Sentara Leigh Hospital and one of 111 doctors at City of Hope Comprehensive Cancer Center who specialize in General Surgery. She also speaks multiple languages, including Spanish and Farsi. She has more than 10 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2022 - 2024
Old Dominion UniversityResidency, Surgery, 2013 - 2022
National Cancer Institute Surgical Oncology Research, Immunotherapy, 2015 - 2019- Eastern Virginia Medical SchoolClass of 2014
University of Arizona College of MedicineClass of 2013- Old Dominion UniversityResidency, Surgery
Certifications & Licensure
CA State Medical License 2024 - 2026
NY State Medical License 2022 - 2026
VA State Medical License 2015 - 2025- VA State Medical License 2015 - 2024
DC State Medical License 2016 - 2022
American Board of Surgery Surgery
Publications & Presentations
PubMed
- Correlation Between Grade of Clinical Response to Neoadjuvant Therapy for Rectal Cancer and Oncologic Outcomes in the Era of Watch-and-Wait.Roni Y Rosen, Aron P Bercz, Dana M Omer, Floris S Verheij, Hannah Williams
Diseases of the Colon and Rectum. 2025-03-01 - 3 citationsWatch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapy.Sean J Judge, Parisa Malekzadeh, Marina J Corines, Marc J Gollub, Natally Horvat
Journal of the National Cancer Institute. 2024-11-01 - 20 citationsInternal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.Douglas C Palmer, Beau R Webber, Yogin Patel, Matthew J Johnson, Christine M Kariya
Med. 2022-10-14
Press Mentions
Peripheral Blood from Patients with Metastatic Solid Tumors Is A Source of p53-Reactive T CellsJanuary 29th, 2020
Professional Memberships
- Society of Surgical OncologyMember
Other Languages
- Spanish, Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
